Shaw and Partners is pleased to be appointed as Joint Lead Manager to the proposed capital raising by Gyder Surgical Pty Limited (unlisted).
The Company is proposing to raise approximately A$5.3 million by way of an Unlisted Convertible Note issuance issued at $1.00 per note.
Funds will be used for key personnel hires for US and Australia commercial product launch, the commercial launch in US and Australia (expected H1 2023) and inventory build & working capital.
Gyder Surgical Pty Limited is an Australian medical device company focused on improving the accuracy, cost effectiveness and ease of orthopaedic surgery using patented technology.
The patented GYDER™ System is an intraoperative, surgical navigation tool to assist orthopaedic surgeons to position the prosthetic acetabular cup during hip replacement surgery (initial core use case). The GYDER™ System is a low cost, easy to use alternative to the current crop of complicated and costly navigation products.
The offer is available to Australian Sophisticated and Professional Investors only.
{{data.Symbol}} {{data.CompanyName}} | {{data.Close}} {{data.AsAt | date :'shortTime'}} | {{data.Movement | number : 2}} {{data.MovementPercent | number: 2}}% |